While literature regarding the pathophysiological contributions made by aberrant expression of PRMT9 is scarce, PRMT9 has been demonstrated to promote hepatocellular carcinoma invasion and metastasis [80]. Here, PRMT9 is linked to hepatocellular carcinoma.